Wen Chuan Zhou
Chief Executive Officer chez MEILLEURE HEALTH INTERNATIONAL INDUSTRY GROUP LIMITED
Fortune : 603 948 $ au 31/03/2024
Profil
Wen Chuan Zhou is currently the Vice Chairman & Chief Executive Officer at Meilleure Health International Industry Group Ltd.
She is also a Director at Gongniu Group Co., Ltd.
and Shenzhen Wingor Bio-technology Co., Ltd.
Ms. Zhou completed her undergraduate and graduate degrees at the University of British Columbia in 2007 and 2008 respectively.
She also obtained an MBA from The Chinese University of Hong Kong in 2011.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
28/03/2024 | 31 938 000 ( 0,78% ) | 603 948 $ | 31/03/2024 |
Postes actifs de Wen Chuan Zhou
Sociétés | Poste | Début |
---|---|---|
MEILLEURE HEALTH INTERNATIONAL INDUSTRY GROUP LIMITED | Chief Executive Officer | 01/01/2009 |
GONGNIU GROUP CO.,LTD. | Director/Board Member | 20/05/2021 |
Shenzhen Wingor Bio-technology Co., Ltd.
Shenzhen Wingor Bio-technology Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shenzhen Wingor Bio-technology Co., Ltd. engages in the research and development, and production of anti-tumor biological immune cell products. It offers chimeric antigen receptor T lymphocyte, clustered regulatory interspaced short palindromic repeat, mesenchymal stem cell, methyl triazeno imidazole carboxamide technology, and cryobiomedical technology. The company was founded on March 12, 2013 and is headquartered in Shenzhen, China. | Director/Board Member | - |
Formation de Wen Chuan Zhou
University of British Columbia | Graduate Degree |
The Chinese University of Hong Kong | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
MEILLEURE HEALTH INTERNATIONAL INDUSTRY GROUP LIMITED | Distribution Services |
GONGNIU GROUP CO.,LTD. | Producer Manufacturing |
Entreprise privées | 1 |
---|---|
Shenzhen Wingor Bio-technology Co., Ltd.
Shenzhen Wingor Bio-technology Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shenzhen Wingor Bio-technology Co., Ltd. engages in the research and development, and production of anti-tumor biological immune cell products. It offers chimeric antigen receptor T lymphocyte, clustered regulatory interspaced short palindromic repeat, mesenchymal stem cell, methyl triazeno imidazole carboxamide technology, and cryobiomedical technology. The company was founded on March 12, 2013 and is headquartered in Shenzhen, China. | Commercial Services |